Timothy F. Gallagher

4.6k citations

20 papers · 4.0k indexed · 2 hit papers · h-index 11

Co-authors: Jerry L. Adams John C. Lee Dean E. McNulty Peter McDonnell Sanjay Kumar Peter R. Young Megan M. McLaughlin George P. Livi
Topics: Cytokine Signaling Pathways and Interactions (6 papers)Synthesis and biological activity (5 papers)Melanoma and MAPK Pathways (4 papers)
Cited by: Immunology Cancer Research Molecular Biology
Journals: Nature Journal of Biological Chemistry Journal of Medicinal Chemistry
Partner nations: United States United Kingdom Germany

In The Last Decade

Timothy F. Gallagher

20 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1994 2.9k citations John C. Lee, Jeffrey T. Laydon et al. Nature profile →
Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Site

1997 519 citations Peter R. Young, Megan M. McLaughlin et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Timothy F. Gallagher

Since Specialization

Citations

This map shows the geographic impact of Timothy F. Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy F. Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy F. Gallagher more than expected).

Fields of papers citing papers by Timothy F. Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy F. Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy F. Gallagher. The network helps show where Timothy F. Gallagher may publish in the future.

Co-authorship network of co-authors of Timothy F. Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy F. Gallagher. A scholar is included among the top collaborators of Timothy F. Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy F. Gallagher. Timothy F. Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acylprolinamides: A new class of peptide deformylase inhibitors with in vivo antibacterial activity 2012 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey M. Axten,Jesús R. Medina,Charles W. Blackledge,Céline Duquenne,Seth W. Grant,Mark A. Bobko,(unknown),William H. Miller,(unknown),Timothy F. Gallagher,Swarupa G. Kulkarni,(unknown),Glenn S. Van Aller,(unknown),Paris Ward,Nino Campobasso	5
2	Rapid synthesis of diversely functionalized 3,4,7-trisubstituted indoles 2011 ·Tetrahedron Letters ·Seth W. Grant,Timothy F. Gallagher,Mark A. Bobko,Céline Duquenne,Jeffrey M. Axten	6
3	A novel method for the 1,2-carbonyl transposition of pleuromutilins 2010 ·Tetrahedron Letters ·Céline Duquenne,Timothy F. Gallagher,Jeffrey M. Axten	4
4	Phenoxypyrimidine inhibitors of p38α kinase 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey C. Boehm,Michael J. Bower,Timothy F. Gallagher,Shouki Kassis,Stephen R. Johnson,Jerry L. Adams	34
5	Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jerry L. Adams,Jeffrey C. Boehm,Timothy F. Gallagher,Shouki Kassis,Edward F. Webb,Ralph Hall,Margaret E. Sorenson,Ravi S. Garigipati,Don E. Griswold,John C. Lee	89
6	Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes 1998 ·Bioorganic & Medicinal Chemistry Letters ·Jerry L. Adams,Jeffrey C. Boehm,Shouki Kassis,Peter D. Gorycki,Edward F. Webb,Ralph Hall,Margaret E. Sorenson,John C. Lee,Andrew D. Ayrton,Don E. Griswold,Timothy F. Gallagher	88
7	Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Sitebreakdown → 1997 ·Journal of Biological Chemistry ·Peter R. Young,Megan M. McLaughlin,Sanjay Kumar,Shouki Kassis,Michael L. Doyle,Dean E. McNulty,Timothy F. Gallagher,(unknown),Peter McDonnell,Steven A. Carr,Michael J. Huddleston,George Seibel,Terence G. Porter,George P. Livi,Jerry L. Adams,John C. Lee	519
8	ChemInform Abstract: Nucleophilic C‐Glycosyl Donors for C‐Glycoside Synthesis 1997 ·ChemInform ·Jean‐Marie Beau,Timothy F. Gallagher	4
9	ChemInform Abstract: 1‐Substituted 4‐Aryl‐5‐pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5‐Lipoxygenase and Cyclooxygenase Inhibitory Potency. 1997 ·ChemInform ·Jeffrey C. Boehm,(unknown),Margaret E. Sorenson,Ravi S. Garigipati,Timothy F. Gallagher,(unknown),Jeremy N. Bradbeer,A M Badger,Jeffrey T. Laydon,(unknown),Leonard M. Hillegass,Don E. Griswold,John Breton,(unknown),Jerry L. Adams	5
10	Atoms and Molecules in Intense Fields 1997 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·Lorenz S. Cederbaum,(unknown),L. J. Frasinski,(unknown),Timothy F. Gallagher,(unknown),(unknown),(unknown),(unknown)	12
11	Synthesis of 4-[2-(4-Azidophenyl)-5-(3-iodo-125I-phenyl)-1H-imidazol-4-yl]pyridine (SB 206718-[125I]), a pyridinyl imidazole cytokine inhibitor 1996 ·Journal of Labelled Compounds and Radiopharmaceuticals ·(unknown),Scott W. Landvatter,Timothy F. Gallagher	2
12	1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency 1996 ·Journal of Medicinal Chemistry ·Jeffrey C. Boehm,(unknown),Margaret E. Sorenson,Ravi S. Garigipati,Timothy F. Gallagher,(unknown),Jeremy N. Bradbeer,Alison M. Badger,Jeffrey T. Laydon,John C. Lee,Leonard M. Hillegass,D.E. Griswold,John Breton,Marie Chabot‐Fletcher,Jerry L. Adams	97
13	2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis 1995 ·Bioorganic & Medicinal Chemistry Letters ·Timothy F. Gallagher,(unknown),Ravi S. Garigipati,Margaret E. Sorenson,(unknown),Dennis Lee,Paul E. Bender,John C. Lee,Jeffrey T. Laydon,Don E. Griswold,Marie Chabot‐Fletcher,John Breton,Jerry L. Adams	119
14	A protein kinase involved in the regulation of inflammatory cytokine biosynthesisbreakdown → 1994 ·Nature ·John C. Lee,Jeffrey T. Laydon,Peter McDonnell,Timothy F. Gallagher,Sanjay Kumar,David I. S. Green,Dean E. McNulty,(unknown),Julie Keys,(unknown),James E. Strickler,Megan M. McLaughlin,Ivo R. Siemens,(unknown),George P. Livi,John R. White,Jerry L. Adams,Peter R. Young	2949
15	Regioselective synthesis of .DELTA.6-, .DELTA.7-, and .DELTA.8-14.alpha.-cyanosterol derivatives: versatile precursors to 14.alpha.-demethylase inhibitors 1992 ·The Journal of Organic Chemistry ·Timothy F. Gallagher,Jerry L. Adams	10
16	Steroidal acetylenes: Mechanism-based inactivators of lanosterol 14α-demethylase 1991 ·Bioorganic Chemistry ·Mary J. Bossard,Thaddeus A. Tomaszek,Timothy F. Gallagher,Brian W. Metcalf,Jerry L. Adams	9
17	C-7 functionalization of 6,7-dihydro[5H]pyrrolo[1,2-a]imidazoles: Activation via quaternization with MEMCl 1989 ·Tetrahedron Letters ·Timothy F. Gallagher,Jerry L. Adams	10
18	Enhancement of the autoionization rate of two-photon excited states of Ba (6d_{5/2}nd_{5/2(3/2)})_{J=4} near the Ba^{+} 6d_{3/2} limit 1984 ·Physical review. A, General physics ·R. Kachru,N. H. Tran,(unknown),Timothy F. Gallagher	14
19	Generation of microwaves by mixing two optical frequencies in a nonlinear crystal: a novel approach to high-bandwidth optical mixers 1984 ·Optics Letters ·N. H. Tran,(unknown),G. C. Bjorklund,R. Kachru,Timothy F. Gallagher	4
20	Synthesis of methyl 2-acetamido-2,3,6-trideoxy-β-l-lyxo-hexopyranoside 1983 ·Carbohydrate Research ·Timothy F. Gallagher,Derek Horton	15

About Timothy F. Gallagher

Timothy F. Gallagher is a scholar working on Pharmacology, Oncology and Organic Chemistry, having authored 20 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), Synthesis and biological activity (5 papers) and Melanoma and MAPK Pathways (4 papers). The work is most often cited by research in Immunology (827 citations), Cancer Research (563 citations) and Molecular Biology (2.5k citations). Timothy F. Gallagher has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jerry L. Adams, John C. Lee, Dean E. McNulty, Peter McDonnell, Sanjay Kumar, Peter R. Young, Megan M. McLaughlin, George P. Livi, Jeffrey T. Laydon and David I. S. Green. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact